Difficulty: Easy
Correct Answer: all of the above
Explanation:
Introduction:
Medical devices revolutionize care but create new infection risks. This question integrates biomaterials science, innate immunity, and clinical management to explain why plastic implants are frequent sources of healthcare-associated infections.
Given Data / Assumptions:
Concept / Approach:
Plastic surfaces permit rapid conditioning by host proteins, followed by bacterial adhesion and biofilm formation. Within biofilms, extracellular polymeric substances impede neutrophil migration and phagocytosis, and diffusion barriers reduce antibiotic penetration. Furthermore, the lack of integrin ligands and the smooth, hydrophobic nature of plastics impair phagocyte motility. Persistent device infections often require device removal because antimicrobial therapy alone rarely eradicates mature biofilms.
Step-by-Step Solution:
Recognize that biofilm formation is common on plastic devices.
Explain that neutrophils/macrophages have difficulty crawling and engaging targets on plastic and within EPS matrices.
Link biofilm tolerance to clinical failure of antibiotics.
Conclude that surgical explantation is frequently necessary to cure infection.
Verification / Alternative check:
Clinical guidelines recommend removal of infected central lines or prostheses when feasible, reflecting the recalcitrance of biofilm-associated infections.
Why Other Options Are Wrong:
Each individual statement is accurate but partial; together they form the complete explanation, making the comprehensive option correct.
Common Pitfalls:
Overreliance on antibiotics without addressing the device as the nidus leads to recurrent or persistent infections.
Final Answer:
all of the above — impaired phagocyte function on plastics, biofilm protection, and the need for device removal explain the risk.
Discussion & Comments